Charity news / by Jennifer Kelly
Tue, 07/13/2021 - 09:00

 

We are extremely proud to announce that the Grace Kelly Childhood Cancer Trust has received confirmation that we have been accepted by the panel at the Association of Medical Research Charities as an accredited member.

The Association of Medical Research Charities is a membership organisation dedicated to supporting medical research charities through research and innovation. They ensure members only fund the best research by setting out expected standards and through auditing charity funding processes. 

Research funding that is provided from AMRC members is eligible for the Charity Research Support Fund (CRSF). This fund adds up to an additional 19 pence for every charity pound we raise for university- based research. This means that the funds we raise as a charity will go even further and help to make a bigger difference.

 

To be awarded membership of the AMRC is the hallmark of quality research funding, so to receive this is a big achievement for the GKCCT.

Over the last 12 months, we have worked hard to develop our processes to demonstrate that we follow the AMRC's rigorous standards in peer review. Our comprehensive research strategy, policies and expert-led Research Advisory Panel means that the decisions on the research we fund are made by those with the most expertise. 

Research funding that is provided from AMRC members is eligible for the Charity Research Support Fund (CRSF). This fund adds up to an additional 19 pence for every charity pound we raise for university- based research. This means that the funds we raise as a charity will go even further and help to make a bigger difference.

We would like to thank each member of our Research Advisory Panel for their time and work in supporting us in this venture. The panel comprises of experts in the field of paediatrics, oncology, General Practice and research. It also contains two parent experts as well. Meet our research advisory panel.

This process has taken hard work but something we have been determined to do. Research remains a vital aim of the Grace Kelly Childhood Cancer Trust because we need kinder and more effective treatments for children with cancer. We are working to fund world- class research into rare, aggressive childhood cancers including rhabdoid tumours and other extremely aggressive cancer types.

By working to improve the diagnosis and treatment of cancers with poor prognoses, we are working to improve the survival rates of children with cancer over time.

Over the last few decades, advances in treatment for some childhood cancers has resulted in improved overall survival rates for children. Some cancer types now have relatively good outcomes, but for other rarer, aggressive cancers, there has been little or no improvement in survival rates. It is usually these cancer types that we concentrate on as we are determined to continue the fight against the biggest medical cause of death of children in the UK, childhood cancer.